Literature DB >> 2296038

Cyclization-activated prodrugs. Basic carbamates of 4-hydroxyanisole.

W S Saari1, J E Schwering, P A Lyle, S J Smith, E L Engelhardt.   

Abstract

A series of basic carbamates of 4-hydroxyanisole was prepared and evaluated as progenitors of this melanocytotoxic phenol. All of the carbamates were relatively stable at low pH but released 4-hydroxyanisole cleanly at pH 7.4 at rates that were structure dependent. A detailed study of the N-methyl-N-[2-(methylamino)ethyl]carbamate showed that generation of the parent phenol followed first-order kinetics with t1/2 = 36.3 min at pH 7.4, 37 degrees C, and was accompanied by formation of N,N'-dimethylimidazolidinone. These basic carbamates are examples of cyclization-activated prodrugs in which generation of the active drug is not linked to enzymatic cleavage but rather depends solely upon a predictable, intramolecular cyclization-elimination reaction.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2296038     DOI: 10.1021/jm00163a016

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  15 in total

Review 1.  Cyclization-activated prodrugs.

Authors:  Paula Gomes; Nuno Vale; Rui Moreira
Journal:  Molecules       Date:  2007-11-12       Impact factor: 4.411

2.  A genetically engineered thermally responsive sustained release curcumin depot to treat neuroinflammation.

Authors:  S Michael Sinclair; Jayanta Bhattacharyya; Jonathan R McDaniel; David M Gooden; Ramesh Gopalaswamy; Ashutosh Chilkoti; Lori A Setton
Journal:  J Control Release       Date:  2013-07-03       Impact factor: 9.776

3.  Thermally-Induced Substrate Release Via Intramolecular Cyclizations of Amino Esters and Amino Carbonates.

Authors:  Ralph J Knipp; Rosendo Estrada; Palaniappan Sethu; Michael H Nantz
Journal:  Tetrahedron       Date:  2014-05-01       Impact factor: 2.457

4.  In vivo activity in a catalytic antibody-prodrug system: Antibody catalyzed etoposide prodrug activation for selective chemotherapy.

Authors:  D Shabat; H N Lode; U Pertl; R A Reisfeld; C Rader; R A Lerner; C F Barbas
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-12       Impact factor: 11.205

5.  Visible-to-NIR-Light Activated Release: From Small Molecules to Nanomaterials.

Authors:  Roy Weinstain; Tomáš Slanina; Dnyaneshwar Kand; Petr Klán
Journal:  Chem Rev       Date:  2020-10-30       Impact factor: 60.622

6.  The synthesis of a c(RGDyK) targeted SN38 prodrug with an indolequinone structure for bioreductive drug release.

Authors:  Baohua Huang; Ankur Desai; Shengzhuang Tang; Thommey P Thomas; James R Baker
Journal:  Org Lett       Date:  2010-04-02       Impact factor: 6.005

7.  Bioreversible derivatives of phenol. 1. The role of human serum albumin as related to the stability and binding properties of carbonate esters with fatty acid-like structures in aqueous solution and biological media.

Authors:  Jesper Østergaard; Claus Larsen
Journal:  Molecules       Date:  2007-10-30       Impact factor: 4.411

Review 8.  Improved biochemical strategies for targeted delivery of taxoids.

Authors:  Thota Ganesh
Journal:  Bioorg Med Chem       Date:  2007-03-18       Impact factor: 3.641

9.  Head-to-Head Comparison of Selected Extra- and Intracellular CO-Releasing Molecules on Their CO-Releasing and Anti-Inflammatory Properties.

Authors:  Yingchun Li; Lars Hemmersbach; Bernhard Krause; Nikolay Sitnikov; Anna Schlundt Née Göderz; Diego O Pastene Maldonado; Hans-Günther Schmalz; Benito Yard
Journal:  Chembiochem       Date:  2021-10-26       Impact factor: 3.461

Review 10.  Organic carbamates in drug design and medicinal chemistry.

Authors:  Arun K Ghosh; Margherita Brindisi
Journal:  J Med Chem       Date:  2015-01-07       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.